Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Non Operating Income (2016 - 2026)

Apyx Medical filings provide 12 years of Non Operating Income readings, the most recent being -$1.2 million for Q4 2025.

  • On a quarterly basis, Non Operating Income rose 23.98% to -$1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.4 million, a 70.58% decrease, with the full-year FY2025 number at -$4.4 million, up 1.64% from a year prior.
  • Non Operating Income hit -$1.2 million in Q4 2025 for Apyx Medical, down from -$1.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $622000.0 in Q2 2022 to a low of -$4.6 million in Q4 2023.
  • Median Non Operating Income over the past 5 years was -$186000.0 (2021), compared with a mean of -$579500.0.
  • Biggest five-year swings in Non Operating Income: soared 760.0% in 2021 and later crashed 111400.0% in 2025.
  • Apyx Medical's Non Operating Income stood at -$184000.0 in 2021, then soared by 110.33% to $19000.0 in 2022, then plummeted by 24547.37% to -$4.6 million in 2023, then soared by 67.23% to -$1.5 million in 2024, then grew by 23.98% to -$1.2 million in 2025.
  • The last three reported values for Non Operating Income were -$1.2 million (Q4 2025), -$1.0 million (Q3 2025), and -$1.1 million (Q2 2025) per Business Quant data.